C FIN INT INV(00721) received additional resumption guidelines
China Finance International (00721) announced that on January 2, 2025, the company received the following notice from the Hong Kong Stock Exchange...
C FIN INT INV (00721) announced on January 2, 2025, that it has received the following additional resumption guidelines from the Stock Exchange:
- Comply with Rule 13.92 of the Listing Rules. The Stock Exchange stated that the company must take remedial actions and fully comply with the Listing Rules to be reinstated for trading in its securities. The company is responsible for developing a resumption action plan. The Stock Exchange also indicated that it may amend the resumption guidelines or provide further guidance at an appropriate time. The company is currently taking appropriate measures to comply with the resumption guidelines and seeks to resume trading of its shares as soon as possible.
Related Articles

Sanbase Corp (08501) released its annual financial performance, with shareholders' net loss of 13.594 million Hong Kong dollars, a 15.24% decrease year-on-year.

SIPAI HEALTH (00314) spent HKD 238,000 to buy back 192,800 shares on June 18th.

PW MEDTECH (01358) spent HKD 219,700 to repurchase 191,000 shares on June 18th.
Sanbase Corp (08501) released its annual financial performance, with shareholders' net loss of 13.594 million Hong Kong dollars, a 15.24% decrease year-on-year.

SIPAI HEALTH (00314) spent HKD 238,000 to buy back 192,800 shares on June 18th.

PW MEDTECH (01358) spent HKD 219,700 to repurchase 191,000 shares on June 18th.

RECOMMEND





